Company / Operating Margin
Arrowhead Pharmaceuticals Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
11.9%
FY2025
5-year range
-16927.1% / 11.9%
FY2021-FY2025
Trend
+100.1%
vs FY2024
Sector context
#39 of 136
Health Care
What the data says
At 11.9%, Arrowhead Pharmaceuticals's operating margin ranks #39 of 136 in the Health Care sector. Operating Margin returned to growth in FY2025 after 2 years of decline, reaching 11.9%.
Based on SEC 10-K filings.
11.9% in FY2025 with a 5-year CAGR of +117.7%.
Improved from -107.8% to 11.9% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +117.7pp
- 5-Year Change
- +117.7pp
- 10-Year Change
- -
Sector benchmark
#39 of 136 in Health CareTop 29% of 136This company 11.9% Sector average -778.9%
▼
+101.5% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 100.1% year-over-year.
- Currently 790.8pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 11.9% | +100.1% |
| FY2024 | -16927.1% | -15606.7% |
| FY2023 | -107.8% | -1.8% |
| FY2022 | -105.9% | +1.8% |
| FY2021 | -107.8% | -1.8% |
| FY2020 | -105.9% | +10.1% |
| FY2019 | -117.8% | +99.8% |
| FY2018 | -51627.1% | -105.5% |
| FY2017 | -25124.1% | +51.3% |
| FY2016 | -51627.1% | -509.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026